Key result
BP self-monitoring in prehypertension elicits ~£41 median willingness to pay, driven by perceived benefits.
Why the study?
Prehypertension affects around 40% of adults and increases cardiovascular risk, but the economic value and willingness to pay for blood pressure self-monitoring interventions in this group were unknown.
What is the willingness to pay for blood pressure self-monitoring equipment and support in people with pre-hypertension?
What is the willingness to pay for blood pressure self-monitoring equipment and support in people with pre-hypertension?
Individuals with prehypertension are willing to pay a median of £41.37 for blood pressure self-monitoring equipment and support, driven primarily by perceived benefits and machine functions.
Informs shared decision-making on self-monitoring uptake in prehypertension; extends patient valuation data but leaves open real-world cost-effectiveness.
Prehypertension is defined as blood pressure (BP) between 120–139/80–89 mmHg. It affects around 40% of adults, increasing their risk of developing hypertension and cardiovascular disease-related conditions. The “Risk rEduction interVEntion for Raised blood preSsurE” (REVERSE) feasibility study investigated whether self-monitoring of BP was acceptable and feasible for managing prehypertension. As part of REVERSE, a willingness-to-pay (WTP) analysis assessed the economic value of the BP self-monitoring intervention. A WTP questionnaire asked participants how much and why they would be willing to pay for a BP machine and for additional support and training around BP self-monitoring. The associations between the total WTP amount (for the BP machine plus the additional support and training) and participants’ socio-demographic and clinical characteristics were investigated using generalised linear modelling (GLM). WTP data was collected from 66 participants (median age: 58.50 years; females: 59.09%). Most of the participants (72.73%) lived in areas of low socio-economic deprivation. The median total WTP amount was £41.37 in 2024 prices (interquartile range: £36.20 to £93.09). The BP machine functions/facilities, the amount reflecting potential benefit, and being a reasonable value were the most cited reasons behind the valuations. The GLM regression showed that higher WTP values were associated with the functions/facilities and potential benefit of the BP machine. We believe this to be the first study to provide insights around the economic value of BP self-monitoring in prehypertension. Further research based on larger, and more representative, samples is needed to validate these findings.
No takes yet. Share an insight, caveat, or question.
Benedetto et al. (2026) studied this question. Blood pressure self-monitoring and support in prehypertension had a median willingness-to-pay of £41.37, with higher valuations linked to machine functions and perceived potential benefits.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: